Key takeaways
- Elevated prolactin has several possible causes, including medicines, pregnancy, an underactive thyroid and pituitary conditions. Endocrine Society overview.
- Some people with raised prolactin and few or no symptoms do not need treatment. The cause and clinical picture guide the decision. Endocrine Society guidance.
- Cabergoline has good evidence for lowering prolactin in appropriate patients, including a trial showing better results than bromocriptine in women with prolactin-related absent periods. Comparative trial.
- Long-term treatment needs a monitoring plan. Product information includes heart-valve and fibrotic-disease precautions. UK Dostinex prescribing information.
- New compulsive gambling, spending or sexual urges can be medicine-related and should be reported, not hidden out of embarrassment. Dostinex safety warnings.
A raised prolactin result can send a person from a routine blood test to searches about pituitary tumours within minutes. Sometimes a tumour is the explanation. Sometimes the cause is a medicine, another hormonal condition or a finding that does not require treatment.
Cabergoline, including the Dostinex brand, belongs in that investigation rather than ahead of it. Lowering a number is useful when it addresses the diagnosed problem, not simply because the result sits outside a reference range.
Does high prolactin mean a pituitary tumour?
No. A prolactinoma is one possibility, not the diagnosis attached to every raised result.
Prolactin normally rises during pregnancy and breastfeeding. Certain medicines, thyroid disease and kidney or liver disease can also raise it. Sometimes testing for macroprolactin, a form that behaves differently in the body, helps explain the result. An MRI is considered when a pituitary tumour is suspected, rather than being an automatic response to every abnormal test. Endocrine Society overview.
Bring the actual laboratory report and a complete medicine list to the appointment. Do not stop a suspected medicine yourself, especially psychiatric treatment. Our thyroid hormone comparison explains another part of endocrine care; it is not a shortcut to identifying the cause of a prolactin result.
How much can cabergoline help?
It can be highly useful for an established prolactin disorder, but a trial result is not a personal guarantee.
Cabergoline is a dopamine agonist: it acts on a signalling pathway that normally restrains prolactin release. In prolactinomas, dopamine-agonist treatment can lower prolactin and reduce tumour size. Endocrine Society treatment information.
In a landmark trial of 459 women with hyperprolactinaemic amenorrhoea, stable normal prolactin levels were achieved in 83% receiving cabergoline versus 59% receiving bromocriptine. Cabergoline was also better tolerated. Those figures concern a defined population and comparison, not all causes of raised prolactin or every fertility problem. Cabergoline versus bromocriptine trial.
| What is being followed | Why it matters |
|---|---|
| Prolactin results | Whether the biochemical problem is responding |
| Symptoms and menstrual function | Whether treatment is making a clinical difference |
| Tumour findings, where relevant | Whether the pituitary condition is responding |
| Adverse effects | Whether continuing treatment remains worthwhile |
Why does heart monitoring appear in the leaflet?
Because long-term cabergoline treatment requires attention to valve disease and fibrosis, even when someone feels well.
The UK Dostinex information calls for cardiovascular assessment, including an echocardiogram, before long-term treatment and follow-up during it. The treating specialist should explain which monitoring schedule applies. It would be misleading to describe the risk as negligible or say that symptom checks alone are always enough. Dostinex prescribing information.
Persistent cough, breathlessness, chest discomfort or new swelling warrants assessment. More everyday problems include nausea, dizziness and a drop in blood pressure on standing. Do not drive if sleepy or affected by sudden sleep episodes.
Can cabergoline affect behaviour or fertility?
Yes. Both are worth discussing before treatment, not only if a problem develops.
Dopamine agonists can cause impulse-control problems, including compulsive gambling, spending or sexual behaviour. Tell the prescriber about unfamiliar, hard-to-control urges. A partner or family member may notice the change first. Dostinex warnings.
Ovulation and fertility may return as prolactin improves. Discuss contraception or pregnancy plans early and contact the treating team if pregnancy occurs. Dostinex pregnancy information. A prolactin disorder is also different from the testosterone-treatment question explored in enclomiphene versus clomiphene.
Do and don’t
Do: Ask what is causing the raised result, what treatment is intended to improve and how follow-up will work.
Don’t: Use cabergoline as a general “hormone-balancing” product, stop another medicine yourself or dismiss new compulsive behaviour.
